Clinical Research Details

Clinical Research

SAGE-PsA Study Sex- And Gender-based analysis of the Effectiveness of advanced therapies in Psoriatic Arthritis

Study Description

The purpose of this study is to understand how sex and gender influence response to advanced therapies (also known as “biologic treatments”) in Psoriatic Arthritis (PsA). We hope to discover causes that explain why men and women with PsA respond differently to treatments. This study should take approximately 3 years to complete. You will be expected to participate for up to 1 year.

Inclusion/Exclusion Criteria

Inclusion criteria

Patients with a rheumatologist-confirmed diagnosis of PsA who are initiating advanced therapy for peripheral musculoskeletal manifestations of PsA 

 Exclusion criteria

  • Unable to read or write
  • Unable to sign informed consent
  • Cannot return for a follow up visit
  • The drug is given for another indication and not for active PsA (e.g. psoriasis, IBD)
  • Pregnant women

Open Enrollment

Contact Name: Caroline Howard
Contact Phone: (904) 633-0914
Contact Email: caroline.howard@jax.ufl.edu

Investigators


Gurjit S. Kaeley, M.B.B.S. (M.D.)
Medicine